This inventor holds 1 USPTO granted patent. Top assignee: National Research Council of Canada. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Arsalan Haqqani: Innovator in Therapeutic Compounds
Introduction
Arsalan Haqqani is a notable inventor based in Kanata, Canada. He has made significant contributions to the field of therapeutic compounds, particularly in relation to the blood-brain barrier. His innovative work aims to address critical medical challenges, including lysosomal storage diseases and α-synucleinopathies.
Latest Patents
Haqqani holds a patent for "Blood-brain barrier transmigrating therapeutic compounds and uses thereof." This invention involves a compound that includes an antibody or a fragment capable of crossing the blood-brain barrier (BBB). It also encompasses a polypeptide aimed at treating lysosomal storage disease (LSD) and α-synucleinopathies. The patent outlines pharmaceutical compositions and methods for effectively treating these conditions.
Career Highlights
Arsalan Haqqani is affiliated with the National Research Council of Canada, where he continues to advance his research and development efforts. His work is pivotal in the exploration of new therapeutic avenues for complex neurological disorders.
Collaborations
Haqqani collaborates with esteemed colleagues, including Hung Fang and Danica Stanimirovic. These partnerships enhance the scope and impact of his research, fostering innovation in the field.
Conclusion
Arsalan Haqqani's contributions to the development of therapeutic compounds demonstrate his commitment to addressing significant health challenges. His innovative patent and collaborative efforts position him as a key figure in the advancement of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile